Showing 1 - 20 results of 38,720 for search '(((( 50 ((ms decrease) OR (_ decrease)) ) OR ( 59 a decrease ))) OR ( 100 nm decrease ))*', query time: 0.77s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

    Published 2021
    “…(b) Prostate cancer incidence in male SLE cohort is significantly decreased by SLE status (OR 0.23, 95% CI 0.089, 0.50, p = 0.0053).…”
  7. 7
  8. 8
  9. 9
  10. 10

    RhpMS and DrmMS dose-response curves. by Megan Leander (459603)

    Published 2015
    “…<p>RhpMS dose dependently decreased <i>R</i>. <i>prolixus</i> cardiac contractility with an EC50 ∼ 140 nM. …”
  11. 11

    Genes whose expression was decreased by 100 nM ouabain by more than 1.3-fold. by Larisa V. Smolyaninova (3600053)

    Published 2019
    “…<p>Genes whose expression was decreased by 100 nM ouabain by more than 1.3-fold.</p>…”
  12. 12
  13. 13

    Ratcheting experiments with 500 nm & 100 nm magnetic particles. by Oladunni B. Adeyiga (10164275)

    Published 2021
    “…<p>A) Ratcheting experiments demonstrating ratcheting time needed for particle accumulation in the collection region. A-C) 100 nm and 500 nm particles accumulate, with 100 nm particles needing a longer ratcheting time. …”
  14. 14

    DART-ID decreases missing datapoints across runs. by Albert Tian Chen (6900215)

    Published 2019
    “…Only peptides seen in >50% of experiments are included. (<b>b</b>) Decrease in missing data across all runs after applying DART-ID, for SCoPE-MS and the two bulk sets from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007082#pcbi.1007082.g004" target="_blank">Fig 4</a> at 1% FDR. …”
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Two fully automated segmentation pipelines used to determine change in whole brain volume. by Renxin Chu (5169857)

    Published 2018
    “…Images are from a 51-year-old man with relapsing-remitting multiple sclerosis at baseline and 4.5 years later; baseline disease duration = 30.1 years; baseline/follow-up Expanded Disability Status Scale score = 0/0, timed 25-foot walk = 5.0/4.0 seconds, and BPF = 0.802/0.798. PBVC was -0.9% (decreased) over the study period. …”